Press

See Press-related news articles in "News" Tab

November 15, 2022

Promaxo Announces Expanded Asset Financing Agreement with kineo finance to Support Continued Growth Plans

“We are happy to announce our expanded financing agreement with kineo finance. kineo finance has been a valuable partner in creating a direct leasing solution since we began our commercialization efforts, and we appreciate their confidence and ongoing support,” said Dr. Amit Vohra, Founder and CEO of Promaxo.

October 5, 2022

Promaxo Announces Participation in the Oppenheimer Private Company Showcase: The Next Wave

Promaxo will give a corporate presentation on Tuesday, October 18, 2022 at 10:05 AM PT and host investor 1x1 meetings, which can be requested through Oppenheimer.

October 4, 2022

Promaxo Announces Six System Sales in the Third Quarter 2022

In the third quarter, North Florida Urology Associates in Gainesville, FL, Avant Concierge Urology in Winter Garden, FL, Urology Center of Winter Park in Winter Park, FL, Sovereign Health System in Jersey City, NJ, Jersey Urology Group in Somers Point, NJ, and Urology America MSO in Austin, TX entered into agreements with Promaxo.

September 15, 2022

Promaxo Announces Research Collaboration with the University of Montreal Hospital Research Centre (CRCHUM) for Improved Prostate, Female GYN Cancer Management

Promaxo announced a four-year research collaboration with the University of Montreal Hospital Research Centre (CRCHUM) supporting MRI guided radiation oncology solutions for improved prostate cancer management, female genitourinary (“GU”) and obstetrics and gynecology (“OB/GYN”). The collaboration also aims to support Health Canada regulatory filing requirements.

August 2, 2022

Promaxo Announces Research Collaborations with Leading European University Hospitals: Imperial College London and University Hospital Tuebingen

In collaboration with Imperial College London, Promaxo received a grant and entered into a research agreement for a clinical study comparing Promaxo’s portable MRI and TRUS-Fusion biopsy (software assisted fusion registration with MRI images fused with real time ultrasound images) to assess for accuracy in prostate cancer detection. Promaxo’s partnership with University Hospital Tuebingen includes a clinical collaboration for MR guided prostate interventions, which will be used to support Promaxo system CE Marking in the European Economic Area (EEA).

July 27, 2022

Promaxo Announces Two In-Office MRI Sales in US East Coast

Sovereign Health System, a community healthcare system with specialty urology care provided under Sovereign Health Medical Group in ten offices in New Jersey, and North Florida Urology Associates, a comprehensive urological care practice focused on men’s health with three clinics in Florida, each acquired a Promaxo system.

1 2 3 4 5 6 10